Old world cutaneous leishmaniasis in Iran: clinical variants and treatments

被引:38
作者
Firooz, Alireza [1 ]
Mortazavi, Hossein [2 ]
Khamesipour, Ali [1 ]
Ghiasi, Maryam [2 ]
Abedini, Robabeh [2 ]
Balighi, Kamran [2 ]
Esmaili, Nafiseh [2 ]
Nassiri-Kashani, Mansour [1 ]
Eskandari, S. Ebrahim [1 ]
Mohebali, Mehdi [3 ]
Mohammadi, Akram Mir Amin [1 ]
Dowlati, Yahya [1 ]
机构
[1] Univ Tehran Med Sci, Ctr Res & Training Skin Dis & Leprosy, Tehran, Iran
[2] Univ Tehran Med Sci, Razi Hosp, Dept Dermatol, Tehran, Iran
[3] Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Parasitol & Mycol, Tehran, Iran
关键词
Old World cutaneous leishmaniasis; clinical variants; treatment; pentavalent antimonial; INTRALESIONAL MEGLUMINE ANTIMONIATE; VISCERAL LEISHMANIASIS; AMPHOTERICIN-B; DOUBLE-BLIND; DIAGNOSIS; COMBINATION; EFFICACY; LYMPHADENITIS; MILTEFOSINE; CRYOTHERAPY;
D O I
10.1080/09546634.2019.1704214
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Old World cutaneous leishmaniasis (OWCL) is endemic in Iran and most cases of cutaneous leishmaniasis (CL) are caused by Leishmania major, and then Leishmania tropica, and rarely by Leishmania infantum. Objective: We aimed to describe clinical variants of OWCL and their treatments. Method: Through literature search in PubMed, Scopus and Embase and google scholar, we have found articles about variant clinical pictures of OWCL and their treatments. Results: The following clinical variants of OWCL namely; localized forms, zosteriform, erysipeloid, eczematoid, warty, localized Leishmania lymphadenitis, sporotrichoid, hyperkeratotic, impetiginized, mucosal involvement in CL, lupoid leishmaniasis, chronic lesions due to leishmanization, disseminated cutaneous leishmaniasis, reactivation of CL after transplantation and coexistence of CL with other diseases, are reported from Iran. The mainstay of therapy remains pentavalent antimonial compounds and cryotherapy is an adjuvant to therapy. Treatment with antifungal agents, miltefosine, amphotericin B and herbal extract such as ZH-E have also been used. Treatment of CL in chronic cases and in immunosuppressed patients is difficult and relapse may occur. Conclusion: In clinical variants of CL with long duration and multiple lesions, systemic pentavalent antimonial compounds are first step of therapy. In case of incomplete response or resistant to classic treatment, combination therapy is indicated.
引用
收藏
页码:673 / 683
页数:11
相关论文
共 86 条